Inclusion completed

An Open-label, Multiple-site, Phase I/II Dose Cohort Trial of Modufolin® in Combination with a Fixed Dose of 5-Fluorouracil (5-FU) alone or together with a Fixed Dose of Oxaliplatin or Irinotecan in Patients with Stage IV Colorectal Cancer

Cancer type: Colorectal cancer

Phase: I/II

Principal Investigator: Guren Tormod

Country: NO

Keywords: Norway, Oslo, Colorectal cancer, Modufolin

Status: Inclusion completed

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02244632?term=2014-001862-84&rank=1